Information essential for the nurse to gather when interviewing a young woman who is taking the drug isotretinoin (Accutane) for acne is:

A. While gathering information about drugs previously used is part of a complete medication history, it is not the highest priority for a patient taking isotretinoin. Previous medications can provide context for treatment effectiveness or drug interactions, but the primary concern with isotretinoin is its teratogenicity, not drug history. B. Isotretinoin is highly teratogenic, meaning it can cause severe, life-threatening birth defects if a woman becomes pregnant while taking the medication. Therefore, the current method of birth control is essential information. Women of childbearing potential must use two reliable forms of contraception and undergo regular pregnancy testing before, during, and after treatment. Ensuring effective contraception is critical to preventing pregnancy and protecting fetal development, making this information the highest priority for the nurse to gather. C. Usual weight may influence dosing in some medications, but for isotretinoin, weight is not the primary concern. The drug is usually prescribed in mg/kg/day, but reproductive safety takes precedence over dosing considerations. D. Family history of breast cancer is not relevant to isotretinoin therapy. The drug’s known risks focus on teratogenicity, liver toxicity, hyperlipidemia, and mood changes, not cancer risk. Collecting this information does not affect the patient’s immediate safety while taking isotretinoin.